Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

613 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Contribution of traditional Japanese Kampo medicines, kakkonto with shosaikotokakikyosekko, in treating patients with mild-to-moderate coronavirus disease 2019: Further analysis of a multicenter, randomized controlled trial.
Takayama S, Namiki T, Arita R, Ono R, Kikuchi A, Ohsawa M, Saito N, Suzuki S, Nakae H, Kobayashi S, Yoshino T, Ishigami T, Tanaka K, Takagi A, Yamaguchi T, Ishii T, Hisanaga A, Mitani K, Ito T. Takayama S, et al. Among authors: mitani k. J Infect Chemother. 2023 Nov;29(11):1054-1060. doi: 10.1016/j.jiac.2023.07.013. Epub 2023 Jul 26. J Infect Chemother. 2023. PMID: 37507087 Free article. Clinical Trial.
Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients.
Takayama S, Namiki T, Arita R, Ono R, Kikuchi A, Ohsawa M, Saito N, Suzuki S, Nakae H, Kobayashi S, Yoshino T, Ishigami T, Tanaka K, Nochioka K, Takagi A, Mimura M, Yamaguchi T, Ishii T, Hisanaga A, Mitani K, Ito T. Takayama S, et al. Among authors: mitani k. Front Pharmacol. 2022 Nov 9;13:1008946. doi: 10.3389/fphar.2022.1008946. eCollection 2022. Front Pharmacol. 2022. PMID: 36438822 Free PMC article.
Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation).
Takayama S, Yoshino T, Koizumi S, Irie Y, Suzuki T, Fujii S, Katori R, Kainuma M, Kobayashi S, Nogami T, Yokota K, Yamazaki M, Minakawa S, Chiba S, Suda N, Nakada Y, Ishige T, Maehara H, Tanaka Y, Nagase M, Kashio A, Komatsu K, Nojiri M, Shimooki O, Nakamoto K, Arita R, Ono R, Saito N, Kikuchi A, Ohsawa M, Nakae H, Mitsuma T, Mimura M, Ishii T, Nochioka K, Chiu SW, Yamaguchi T, Namiki T, Hisanaga A, Mitani K, Ito T. Takayama S, et al. Among authors: mitani k. Intern Med. 2023 Jan 15;62(2):187-199. doi: 10.2169/internalmedicine.0027-22. Epub 2022 Nov 2. Intern Med. 2023. PMID: 36328579 Free PMC article.
A Clinical Study of Ninjin'yoeito With Regard to Frailty.
Sakisaka N, Mitani K, Sempuku S, Imai T, Takemoto Y, Shimomura H, Ushiroyama T. Sakisaka N, et al. Among authors: mitani k. Front Nutr. 2018 Sep 24;5:73. doi: 10.3389/fnut.2018.00073. eCollection 2018. Front Nutr. 2018. PMID: 30320119 Free PMC article.
Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunction.
Otsuka Y, Imamura K, Oishi A, Asakawa K, Kondo T, Nakai R, Suga M, Inoue I, Sagara Y, Tsukita K, Teranaka K, Nishimura Y, Watanabe A, Umeyama K, Okushima N, Mitani K, Nagashima H, Kawakami K, Muguruma K, Tsujikawa A, Inoue H. Otsuka Y, et al. Among authors: mitani k. JCI Insight. 2024 Apr 22;9(8):e174179. doi: 10.1172/jci.insight.174179. JCI Insight. 2024. PMID: 38646933 Free article.
613 results